365 related articles for article (PubMed ID: 3010600)
41. Association between laminin-8 and glial tumor grade, recurrence, and patient survival.
Ljubimova JY; Fugita M; Khazenzon NM; Das A; Pikul BB; Newman D; Sekiguchi K; Sorokin LM; Sasaki T; Black KL
Cancer; 2004 Aug; 101(3):604-12. PubMed ID: 15274074
[TBL] [Abstract][Full Text] [Related]
42. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
[TBL] [Abstract][Full Text] [Related]
43. Automated image analysis of glioblastomas and other gliomas.
Martin H; Voss K
Acta Neuropathol; 1982; 58(1):9-16. PubMed ID: 7136520
[TBL] [Abstract][Full Text] [Related]
44. DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome.
Motomura K; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nakazato Y; Tanaka Y; Pierscianek D; Kim YH; Mariani L; Vital A; Ohgaki H
J Neuropathol Exp Neurol; 2012 Aug; 71(8):702-7. PubMed ID: 22805772
[TBL] [Abstract][Full Text] [Related]
45. Karyometric features of low and high grade glial tumors as compared with their MRI appearance.
Scarpelli M; Montironi R; Salvolini U; Messori A; Bartels PH
Anal Quant Cytol Histol; 2004 Apr; 26(2):87-96. PubMed ID: 15131896
[TBL] [Abstract][Full Text] [Related]
46. Real-time quantification of the proliferative state in astrocytomas.
Ricco R; Cimmino A; Renzulli G; Serio G; Lozupone A; Lettini T; Pece A; Giardina C; Delfino VP
Anal Quant Cytol Histol; 2000 Jun; 22(3):213-7. PubMed ID: 10872037
[TBL] [Abstract][Full Text] [Related]
47. Correlates of survival and the Daumas-Duport grading system for astrocytomas.
Kim TS; Halliday AL; Hedley-Whyte ET; Convery K
J Neurosurg; 1991 Jan; 74(1):27-37. PubMed ID: 1984503
[TBL] [Abstract][Full Text] [Related]
48. Cerebral astrocytic neoplasms in the adult: contribution of histologic examination to the assessment of prognosis.
Fulling KH; Nelson JS
Semin Diagn Pathol; 1984 May; 1(2):152-63. PubMed ID: 6100972
[TBL] [Abstract][Full Text] [Related]
49. Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas.
Ohta T; Kim YH; Oh JE; Satomi K; Nonoguchi N; Keyvani K; Pierscianek D; Sure U; Mittelbronn M; Paulus W; Vital A; Yokoo H; McDonald K; Kleihues P; Nazaret N; Barbet F; Lachuer J; Ohgaki H
J Neuropathol Exp Neurol; 2014 Oct; 73(10):908-15. PubMed ID: 25192052
[TBL] [Abstract][Full Text] [Related]
50. Prognostic role of urokinase-type plasminogen activator in human gliomas.
Hsu DW; Efird JT; Hedley-Whyte ET
Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873
[TBL] [Abstract][Full Text] [Related]
51. Activation of EGFR signaling from pilocytic astrocytomas to glioblastomas.
Carvalho PO; Uno M; Oba-Shinjo SM; Rosemberg S; Wakamatsu A; da Silva CC; Teixeira MJ; Marie SK
Int J Biol Markers; 2014 Jun; 29(2):e120-8. PubMed ID: 24170555
[TBL] [Abstract][Full Text] [Related]
52. Microvessel density in brain tumors.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
[TBL] [Abstract][Full Text] [Related]
53. [An analysis of the interconnections between the proliferative activity of benign and anaplastic astrocytomas of the cerebral hemispheres and their histological structural characteristics].
Korshunov AG; Sycheva RV
Zh Vopr Neirokhir Im N N Burdenko; 1997; (1):30-4. PubMed ID: 9148628
[TBL] [Abstract][Full Text] [Related]
54. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
Pedal WP; Warzok RW; Hufnagl P; Roth K
Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
[TBL] [Abstract][Full Text] [Related]
55. Mdr1 mRNA expression differs between grade III astrocytomas and glioblastomas.
Kirches E; Oda Y; Von Bossanyi P; Diete S; Schneider T; Warich-Kirches M; Dietzmann K
Clin Neuropathol; 1997; 16(1):34-6. PubMed ID: 9020393
[TBL] [Abstract][Full Text] [Related]
56. Automated image analysis, histologic malignancy grading, and survival in patients with astrocytic gliomas. Prognostic significance of nuclear count and nuclear area fraction.
Klinken LH; Diemer NH; Gjerris F
Clin Neuropathol; 1984; 3(3):107-12. PubMed ID: 6565536
[TBL] [Abstract][Full Text] [Related]
57. Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas.
Sallinen SL; Sallinen P; Haapasalo H; Kononen J; Karhu R; Helén P; Isola J
Am J Pathol; 1997 Dec; 151(6):1799-807. PubMed ID: 9403731
[TBL] [Abstract][Full Text] [Related]
58. Histopathology, classification, and grading of gliomas.
Kleihues P; Soylemezoglu F; Schäuble B; Scheithauer BW; Burger PC
Glia; 1995 Nov; 15(3):211-21. PubMed ID: 8586458
[TBL] [Abstract][Full Text] [Related]
59. Detection of tumor necrosis factor-alpha protein and messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridization using molecular probes.
Roessler K; Suchanek G; Breitschopf H; Kitz K; Matula C; Lassmann H; Koos WT
J Neurosurg; 1995 Aug; 83(2):291-7. PubMed ID: 7616275
[TBL] [Abstract][Full Text] [Related]
60. Magnetic resonance spectroscopy in intracranial tumours of glial origin.
Jaskólski DJ; Fortuniak J; Majos A; Gajewicz W; Papierz W; Liberski PP; Sikorska B; Stefańczyk L
Neurol Neurochir Pol; 2013; 47(5):438-49. PubMed ID: 24166565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
